# NewLeaf Symbiotics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/newleaf-symbiotics

- Industry: Biotechnology
- Headquarters: St. Louis, US
- Website: www.newleafsym.com
- Total disclosed funding: $121M
- Latest round: Series D (Dec 12, 2023)
- Investors on record: 11

## About

Based in the US, NewLeaf Symbiotics, Inc. focuses on developing innovative agricultural solutions through biological products that enhance crop performance and sustainability.NewLeaf Symbiotics, Inc. was founded in 2012 in St. Louis, US, specializing in advanced agricultural solutions. The company was established by Steve Kahn, who has a history of innovation in the agricultural sector. NewLeaf has successfully completed 8 funding deals, with the latest being a Series D round in December 2023, raising USD 47.006 mn led by Gullspång Re:food. The company’s current valuation is USD 139.038 mn.NewLeaf Symbiotics specializes in advanced agricultural solutions through its innovative product offerings centered on Pink-Pigmented Facultative Methylotrophs (PPFMs). The company’s primary products include TS201 Corn Bioinsecticide, Terrasym 450 Corn Biostimulant, Terrasym 401 Soybean Biostimulant, and Terrasym 402 Peanut Biostimulant. These biologicals improve traditional crop management practices, providing benefits such as increased yield and protection against rootworm damage. NewLeaf serves a diverse customer base including growers and agronomists across various agricultural regions, with significant trials conducted in Missouri, Illinois, and Nebraska, primarily targeting corn, soybean, peanut, and tomato growers.NewLeaf Symbiotics generates revenue through the sale of its specialized agricultural products, marketed business-to-business to farmers and agricultural retailers. Products such as TS201 and Terrasym biostimulants are priced competitively reflecting their proven performance. The revenue stream is bolstered by partnerships with agricultural distributors, ensuring access to the market and fostering strong relationships with end users in the agricultural sector.In December 2023, NewLeaf Symbiotics, Inc. raised USD 45 mn in Series D funding led by Gullspång Re:food, with participation from Leaps by Bayer, S2G Ventures, and Otter Capital. The company plans to utilize this funding to support the development of its technology. Future growth initiatives include launching new products designed to enhance crop yields and expanding into new markets with a focus on regions identified for their potential agricultural viability.

## Funding rounds

- Series D, Dec 12, 2023, $47M — Otter Capital, S2G Ventures, Leaps by Bayer, Gullspång Re:food
- Series D, Feb 14, 2020, $21M — RockPort Capital Partners, Otter Capital, S2G Ventures, Koch Agronomic Services, Leaps by Bayer
- Series C, Sep 7, 2017, $6M — Pangaea Ventures, RockPort Capital Partners, Open Prairie, Otter Capital, Alumni Ventures Group, S2G Ventures, Monsanto Growth Ventures, Lewis & Clark Ventures
- Series C, Jul 9, 2017, $24M — Pangaea Ventures, RockPort Capital Partners, Open Prairie, Otter Capital, Monsanto Growth Ventures, Lewis & Clark Ventures
- Series B, Sep 12, 2014, $17M — Otter Capital
- Series A, Jan 9, 2013, $7M — Pangaea Ventures, RockPort Capital Partners, Open Prairie

## Investors

- Pangaea Ventures (https://capitalatlas.ai/funds/pangaea-ventures) — Series A, Series C
- RockPort Capital Partners (https://capitalatlas.ai/funds/rockport-capital-partners) — Series A, Series C, Series D
- Open Prairie (https://capitalatlas.ai/funds/open-prairie) — Series A, Series C
- Otter Capital (https://capitalatlas.ai/funds/otter-capital) — Series B, Series C, Series D
- Monsanto Growth Ventures (https://capitalatlas.ai/funds/monsanto-growth-ventures) — Series C
- Lewis & Clark Ventures (https://capitalatlas.ai/funds/lewis-clark-ventures) — Series C
- Alumni Ventures Group (https://capitalatlas.ai/funds/alumni-ventures-group) — Series C
- S2G Ventures (https://capitalatlas.ai/funds/s2g-ventures) — Series C, Series D
- Koch Agronomic Services — Series D
- Leaps by Bayer (https://capitalatlas.ai/funds/leaps-by-bayer) — Series D
- Gullspång Re:food (https://capitalatlas.ai/funds/gullspang-re-food) — Series D